Mirae Asset Global Investments
DGX icon

Mirae Asset Global Investments’s Quest Diagnostics DGX Stock Holding History

Mirae Asset Global Investments’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.6M Buy
26,419
+2,784
+12% +$546K 0.01% 575
2026
Q1 		$4.63M Buy
23,635
+2,902
+14% +$564K ﹤0.01% 573
2025
Q4 		$3.6M Buy
20,733
+3,449
+20% +$628K 0.01% 642
2025
Q3 		$3.29M Buy
17,284
+1,877
+12% +$333K 0.01% 620
2025
Q2 		$2.77M Buy
15,407
+830
+6% +$144K 0.01% 623
2025
Q1 		$2.44M Buy
14,577
+1,348
+10% +$221K 0.01% 615
2024
Q4 		$2.02M Buy
13,229
+2,884
+28% +$449K 0.01% 659
2024
Q3 		$1.6M Buy
10,345
+2,852
+38% +$426K 0.01% 699
2024
Q2 		$1.03M Sell
7,493
-42,837
-85% -$5.87M 0.01% 755
2024
Q1 		$6.93M Buy
50,330
+4,464
+10% +$579K 0.02% 792
2023
Q4 		$6.32M Sell
45,866
-44
-0.1% -$5.79K 0.01% 810
2023
Q3 		$5.59M Buy
45,910
+1,281
+3% +$171K 0.01% 832
2023
Q2 		$6.27M Sell
44,629
-3,435
-7% -$474K 0.01% 828
2023
Q1 		$6.8M Sell
48,064
-14,630
-23% -$2.09M 0.02% 780
2022
Q4 		$9.81M Buy
62,694
+540
+0.9% +$77.6K 0.03% 608
2022
Q3 		$7.63M Buy
62,154
+1,521
+3% +$200K 0.02% 671
2022
Q2 		$8.06M Sell
60,633
-3,612
-6% -$492K 0.02% 677
2022
Q1 		$8.79M Buy
64,245
+10,467
+19% +$1.46M 0.02% 708
2021
Q4 		$9.3M Buy
53,778
+10,038
+23% +$1.53M 0.02% 699
2021
Q3 		$6.36M Buy
43,740
+4,513
+12% +$660K 0.02% 775
2021
Q2 		$5.18M Buy
39,227
+3,412
+10% +$447K 0.01% 807
2021
Q1 		$4.6M Buy
35,815
+1,921
+6% +$237K 0.02% 745
2020
Q4 		$4.04M Buy
33,894
+17,646
+109% +$2.15M 0.02% 709
2020
Q3 		$1.86M Buy
16,248
+3,682
+29% +$435K 0.01% 804
2020
Q2 		$1.43M Buy
12,566
+2,409
+24% +$256K 0.01% 794
2020
Q1 		$816K Sell
10,157
-376
-4% -$38.9K 0.01% 885
2019
Q4 		$1.13M Buy
10,533
+1,500
+17% +$156K 0.01% 925
2019
Q3 		$967K Buy
9,033
+624
+7% +$64.1K 0.01% 932
2019
Q2 		$856K Buy
8,409
+266
+3% +$25.6K 0.01% 960
2019
Q1 		$732K Buy
8,143
+1,530
+23% +$133K 0.01% 931
2018
Q4 		$551K Sell
6,613
-277
-4% -$26K 0.01% 954
2018
Q3 		$743K Buy
+6,890
New +$756K 0.01% 935
2018
Q1 		– Sell
-12,439
Closed -$1.23M – 730
2017
Q4 		$1.23M Buy
+12,439
New +$1.18M 0.02% 441
2017
Q3 		– Sell
-2,535
Closed -$281K – 657
2017
Q2 		$281K Sell
2,535
-185
-7% -$19.6K ﹤0.01% 590
2017
Q1 		$267K Buy
+2,720
New +$259K 0.01% 584

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $20.1B AUM 16.62% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Mirae Asset Global Investments's DGX Position: Q2 2026 in Review

Mirae Asset Global Investments increased its Quest Diagnostics (DGX) stake by 12% in Q2 2026, buying an estimated $546K and bringing the position to 26,419 shares worth $5.6M. The position accounts for 0.01% of the portfolio, ranked #575.

Mirae Asset Global Investments first reported a position in DGX in Q1 2017 and has held it in 35 quarters since. The position peaked at $9.81M in Q4 2022. 631 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Mirae Asset Global Investments held 26,419 shares of Quest Diagnostics worth $5.6M as of Q2 2026.
  • Mirae Asset Global Investments bought 2,784 Quest Diagnostics shares in Q2 2026, an estimated $546K.
  • Quest Diagnostics made up 0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #575 holding.
  • Mirae Asset Global Investments first reported a position in Quest Diagnostics in Q1 2017 and has held it in 35 quarters since.
  • Mirae Asset Global Investments's Quest Diagnostics position peaked at $9.81M in Q4 2022.
  • 631 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.